3D Printing

Arcam Solidifies Medical 3D Printing Position with Acquisition of DiSanto

After partnering with medical 3D printing service bureau DiSanto Technology in February of last year, Arcam, the industry leading manufacturer of EBM metal 3D printers, has made the relationship exclusive, acquiring the medical solutions company in order to provide DiSanto Arcam’s customers 3D printed implants and other parts.

The new medical 3D printing division will combine DiSanto’s experience in engineering and manufacturing finished orthopedic implants with Arcam’s electron beam melting technology to serve the companies’ client base, which includes orthopedic and spinal implant companies.  Made up of about 100 employees, DiSanto is already equipped and certified to produce medical grade implants and as a new subsidiary of Arcam, the division will continue with its existing management team. In the last year, the firm earned around $12 million in revenue and an EBIT of $0.6 million USD.  Under the guidance of Viant Capital LLC, Arcam purchased the company with $15.8 million in cash via the execution of stock options issued last February.

arcam acquires disanto medical 3D printing service bureau

Arcam CEO Magnus René said of the purchase, “Through this acquisition Arcam’s offering will cover the entire supply chain for our customers: Metal powders through AP&C, acquired earlier this year, EBM systems and services through Arcam AB and finished products through DiSanto. The acquisition is thus in line with our growth strategy, it complements our technology and product portfolio, and it is immediately accretive. We are very pleased to welcome the skilled DiSanto team to the Arcam group.”

Ronald F. Dunn, President of DiSanto Technology, contributed, “With this deal we will be part of the leading company in 3D-printing in metals. This will enable us to help customers in rapidly developing product applications and to commercially produce products for them with Arcam’s cost-efficient, regulatory-cleared Additive Manufacturing technology. Being part of a larger group will also help in accelerating growth to better serve the growing implant market.”

Arcam’s machines have already been manufacturing FDA-cleared and CE-certified orthopedic implants since 2007, releasing EBM systems designed specifically for the printing of metal orthopedic implants beginning in 2009, and this recent acquisition solidifies the company’s position in the field of orthopedic surgery. As other 3D printer manufacturers expand their own medical 3D printing capabilities with in-house service bureaus, it seems only natural that Arcam would do the same. And, with the ability of 3D printing to create patient-tailored implants designed for maximum effectiveness, the company’s decision to continue down this path is not just good business, but may improve medicine as a whole.